Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1521 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Cara Therapeutics Initiates Pivotal Phase 3 Efficacy Trial of KORSUVA™ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Cara Therapeutics Inc.

Microbot Medical Inc. to Initiate Townhall Meetings

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Microbot Medical Ltd.

Allergy Therapeutics: Trading Update

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Allergy Therapeutics Italia S.R.L. | Allergy Therapeutics | Allergy Therapeutics Iberica

Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Immunovaccine Inc.

ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale.

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Esperite N.V.

Protalix BioTherapeutics’ pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Protalix BioTherapeutics, Inc.

Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Innovate Biopharmaceuticals, Inc.

GTX Corp Silver Sponsor at Super Bowl LII Big Game Experience Showcasing New Line of Biometric Insoles at Gifting Suite

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018

KemPharm to Present at The MoneyShow Orlando Investor Conference

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  KemPharm, Inc.

Oncolix Sponsors Additional Research with MD Anderson Cancer Center

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Oncolix, Inc.

Beleave Receives Notification of Pre-Sale Inspection Date

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Beleave Inc.

Kalytera Announces Grant of Stock Options

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Kalytera Therapeutics, Inc.

SeaSpine Expands Ventura™ NanoMetalene® Implant Offering to Accommodate Larger Range of Posterior Procedures

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  SeaSpine Holdings Corporation

Filament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel Disease

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Filament BioSolutions Inc.

Invuity Announces 2017 Fourth Quarter, Full Year Financial Results and Conference Call Date

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Invuity, Inc.

Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Paratek Pharmaceuticals, Inc.

Quotient Limited to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Quotient Limited

Skyline Medical Projects 100 STREAMWAY System Sales in the U.S. in 2018

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Skyline Medical Inc.

Hemispherx’s Ampligen Highlighted in Review of Role of TLR3 Agonist Support for “Universal” Flu Immunization Development Programs

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Hemispherx BioPharma

Dermira Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Read more ››
By: Nasdaq / GlobenewsWire - 31 Jan 2018
Related companies:  Dermira Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑